GT200900310A - Macrociclos y sus usos - Google Patents
Macrociclos y sus usosInfo
- Publication number
- GT200900310A GT200900310A GT200900310A GT200900310A GT200900310A GT 200900310 A GT200900310 A GT 200900310A GT 200900310 A GT200900310 A GT 200900310A GT 200900310 A GT200900310 A GT 200900310A GT 200900310 A GT200900310 A GT 200900310A
- Authority
- GT
- Guatemala
- Prior art keywords
- macrociclos
- compounds
- manufacture
- effective
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LOS COMPUESTOS DE LA PRESENTE INVENCION SON ADECUADOS COMO AGENTES ACTIVOS EN COMPOSICIONES FARMACEUTICAS QUE SON EFICACES EN PARTICULAR PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS EN LAS QUE LA INVENCION PROPORCIONA ADICIONALMENTE METODO PARA LA FABRICACION DE UN MEDICAMENTO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94177707P | 2007-06-04 | 2007-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200900310A true GT200900310A (es) | 2010-05-21 |
Family
ID=40094226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200900310A GT200900310A (es) | 2007-06-04 | 2009-12-02 | Macrociclos y sus usos |
Country Status (24)
Country | Link |
---|---|
US (2) | US8476224B2 (es) |
EP (1) | EP2170907A2 (es) |
JP (1) | JP2010529076A (es) |
KR (1) | KR101202483B1 (es) |
CN (1) | CN101772506B (es) |
AR (1) | AR066865A1 (es) |
AU (1) | AU2008258639B2 (es) |
BR (1) | BRPI0812340A2 (es) |
CA (1) | CA2688621A1 (es) |
CL (1) | CL2008001613A1 (es) |
CO (1) | CO6270222A2 (es) |
CR (1) | CR11158A (es) |
EA (1) | EA200901613A1 (es) |
EC (1) | ECSP099836A (es) |
GT (1) | GT200900310A (es) |
IL (1) | IL202285A0 (es) |
MA (1) | MA31562B1 (es) |
MX (1) | MX2009013214A (es) |
NZ (1) | NZ581917A (es) |
PE (1) | PE20090318A1 (es) |
TN (1) | TN2009000495A1 (es) |
TW (1) | TW200902540A (es) |
WO (1) | WO2008148754A2 (es) |
ZA (1) | ZA200908262B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009074605A1 (en) | 2007-12-12 | 2009-06-18 | Novartis Ag | Aminothiazoles and their uses |
WO2018073269A1 (en) * | 2016-10-21 | 2018-04-26 | Xellia Pharmaceuticals Aps | Liquid formulations of daptomycin |
CN109485617B (zh) * | 2018-12-11 | 2023-01-31 | 贵州永诺菲特生物制药有限公司 | 一种n-甲基-2-异丙基-4-噻唑甲胺的制备方法 |
WO2024044751A2 (en) * | 2022-08-26 | 2024-02-29 | Wake Forest University Health Sciences | Peroxiredoxin 3 inhibitors and methods of use for treating cancer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0451486B1 (en) | 1990-03-08 | 1995-04-19 | GRUPPO LEPETIT S.p.A. | Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T |
DE9004073U1 (de) | 1990-04-07 | 1990-06-13 | Auto-Kabel Hausen GmbH & Co. Betriebs-KG, 79688 Hausen | Anschlußklemme für Akkumulator o.dgl. |
IL100572A (en) | 1991-01-03 | 1997-01-10 | Lepetit Spa | Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them |
ES2113391T3 (es) * | 1991-08-30 | 1998-05-01 | Biosearch Italia Spa | Factor c2a de antibiotico ge 2270. |
DE69718442T2 (de) | 1996-02-14 | 2003-04-30 | Biosearch Italia Spa | Derivate des antibiotisch wirkenden faktors ge2270 |
JPH1059997A (ja) * | 1996-08-22 | 1998-03-03 | Microbial Chem Res Found | アミチアマイシンアミド誘導体 |
DK1553967T3 (da) * | 2002-06-17 | 2011-08-29 | Naicons S C A R L | Anvendelse af et amidderivat af GE 2270 faktor A3 til behandling af acne |
US20050106159A1 (en) * | 2003-08-12 | 2005-05-19 | Thompson Stuart A. | Campylobacter jejuni outer membrane protein immunogenic composition |
PE20080103A1 (es) * | 2006-05-31 | 2008-04-03 | Novartis Ag | AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu |
PT2097423E (pt) | 2006-12-20 | 2011-06-01 | Novartis Ag | Macrociclos de aminotiazole, seu uso como compostos antibacterianos e processos para a sua produção |
-
2008
- 2008-06-03 AU AU2008258639A patent/AU2008258639B2/en not_active Ceased
- 2008-06-03 PE PE2008000935A patent/PE20090318A1/es not_active Application Discontinuation
- 2008-06-03 KR KR1020097027601A patent/KR101202483B1/ko not_active IP Right Cessation
- 2008-06-03 CL CL2008001613A patent/CL2008001613A1/es unknown
- 2008-06-03 CA CA002688621A patent/CA2688621A1/en not_active Abandoned
- 2008-06-03 CN CN200880101867.9A patent/CN101772506B/zh not_active Expired - Fee Related
- 2008-06-03 BR BRPI0812340-3A2A patent/BRPI0812340A2/pt not_active IP Right Cessation
- 2008-06-03 EA EA200901613A patent/EA200901613A1/ru unknown
- 2008-06-03 TW TW097120619A patent/TW200902540A/zh unknown
- 2008-06-03 NZ NZ581917A patent/NZ581917A/en unknown
- 2008-06-03 EP EP08760422A patent/EP2170907A2/en not_active Withdrawn
- 2008-06-03 MX MX2009013214A patent/MX2009013214A/es active IP Right Grant
- 2008-06-03 US US12/132,377 patent/US8476224B2/en not_active Expired - Fee Related
- 2008-06-03 JP JP2010510764A patent/JP2010529076A/ja active Pending
- 2008-06-03 WO PCT/EP2008/056838 patent/WO2008148754A2/en active Application Filing
- 2008-06-04 AR ARP080102381A patent/AR066865A1/es unknown
-
2009
- 2009-11-23 IL IL202285A patent/IL202285A0/en unknown
- 2009-11-23 ZA ZA200908262A patent/ZA200908262B/xx unknown
- 2009-11-26 TN TNP2009000495A patent/TN2009000495A1/fr unknown
- 2009-12-02 GT GT200900310A patent/GT200900310A/es unknown
- 2009-12-11 CR CR11158A patent/CR11158A/es not_active Application Discontinuation
- 2009-12-30 EC EC2009009836A patent/ECSP099836A/es unknown
- 2009-12-30 CO CO09149375A patent/CO6270222A2/es not_active Application Discontinuation
- 2009-12-30 MA MA32463A patent/MA31562B1/fr unknown
-
2013
- 2013-05-23 US US13/900,866 patent/US8691756B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2008258639B2 (en) | 2012-07-05 |
TW200902540A (en) | 2009-01-16 |
CO6270222A2 (es) | 2011-04-20 |
CN101772506A (zh) | 2010-07-07 |
KR101202483B1 (ko) | 2012-11-16 |
ECSP099836A (es) | 2010-01-29 |
US20130252883A1 (en) | 2013-09-26 |
ZA200908262B (en) | 2010-08-25 |
WO2008148754A2 (en) | 2008-12-11 |
WO2008148754A3 (en) | 2009-03-05 |
US20090186830A1 (en) | 2009-07-23 |
IL202285A0 (en) | 2010-06-16 |
BRPI0812340A2 (pt) | 2015-01-27 |
JP2010529076A (ja) | 2010-08-26 |
AU2008258639A1 (en) | 2008-12-11 |
MX2009013214A (es) | 2010-01-15 |
TN2009000495A1 (en) | 2011-03-31 |
CR11158A (es) | 2010-01-20 |
PE20090318A1 (es) | 2009-04-17 |
MA31562B1 (fr) | 2010-08-02 |
CL2008001613A1 (es) | 2009-05-15 |
CN101772506B (zh) | 2014-02-12 |
CA2688621A1 (en) | 2008-12-11 |
EA200901613A1 (ru) | 2010-06-30 |
US8476224B2 (en) | 2013-07-02 |
US8691756B2 (en) | 2014-04-08 |
NZ581917A (en) | 2011-04-29 |
KR20100021496A (ko) | 2010-02-24 |
EP2170907A2 (en) | 2010-04-07 |
AR066865A1 (es) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2020007218A2 (es) | Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 | |
DOP2012000257A (es) | Derivados del acido 1-amino-2-ciclopropiletilboronico | |
UY31860A (es) | Piridinas de tiazolo como inhibidoras de la adn girasa | |
CR20160014A (es) | Compuestos de éster boronato y composiciones farmacéuticas de los mismos | |
UY31314A1 (es) | Amidas heterociclicas y sus métodos de uso-976 | |
PE20151023A1 (es) | Triazolopirazinas | |
ECSP12011834A (es) | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, métodos para su tratamiento y sus usos. | |
ECSP10010015A (es) | Inhibidores de proteasoma | |
UY33775A (es) | Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
UY33536A (es) | INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS | |
ECSP13013068A (es) | Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2 | |
HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
CR20110216A (es) | Derivados de ácido 1-amino-2-ciclobutiletilborónico | |
ECSP088749A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
UY31322A1 (es) | Amidas heterocíclicas y sus métodos de uso-975 | |
CO6382089A2 (es) | Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias | |
UY31141A1 (es) | Compuestos de piperidina y sus usos | |
CO7151509A2 (es) | Difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos como inhibidores de bace1 | |
PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel | |
CL2011002907A1 (es) | Compuestos derivados de nitrilo; sus composiciones farmacéuticas y su uso para el tratamiento de enfermedades hiperproliferativas. | |
GT200900310A (es) | Macrociclos y sus usos | |
SV2011003839A (es) | Agentes antifungicos | |
CL2021001244A1 (es) | Compuestos antibióticos, métodos de fabricación de los mismos, composiciones farmacéuticas conteniendo los mismos y usos de los mismos |